Since the level of histone acetylation, and conversely deacetylation, can influence gene transcription, the effect of the histone deacetylase (HDAC) inhibitor, TSA on RARβ2 and CYP26A1 expression in RA-resistant lung and breast cancer cells was investigated. This evidence concerns the gene CYP26A1 and breast cancer.